Fox Health

Certain dietary supplements are facing a recall, according to a notice posted to the U.S. Food and Drug Administration’s (FDA) website this week. 

Following Monday’s news of AstraZeneca and Oxford University’s coronavirus vaccine candidate showing up to 90% efficacy in clinical trials, officials at the World Health Organization (WHO) carried a hopeful yet patient message.

A dozen family members who traveled to St. Louis to celebrate their father’s 99th birthday found themselves all infected by the novel coronavirus.

The novel coronavirus has claimed the life of a child in Washington state. 

Plenty of first-time chefs will enter the kitchen on Thursday as coronavirus shifts around typical Thanksgiving traditions and celebrations, but that doesn’t mean it has to end in an injury-riddled disaster.

The Food and Drug Administration on Monday approved Oxlumo to treat a rare genetic disorder affecting the kidneys.

A health official from Ohio's Cleveland Clinic on Monday said nearly 1,000 of the hospital’s caregivers have been affected by COVID-19.

Doctors are flagging a worrying trend amid a spike in coronavirus cases across the U.S.: More kids are contracting the virus, too.

Centers for Disease Control and Prevention (CDC) Director Dr. Robert Redfield on Tuesday said the much-anticipated rollout of a coronavirus vaccine in the United States could be expected by December. 

Coronavirus hospitalizations in Maine have surpassed 100 for the first time, according to state health data. 

Flouting recommendations from federal health officials, a third of parents who responded to a survey said they plan to see their families in-person this year despite the risk of COVID-19. 

New gene-based technology has proven effective in the development of two promising coronavirus vaccine candidates. 

While Oxford University and AstraZeneca announced Monday that their coronavirus vaccine candidate reached up to 90% efficacy in a late-stage clinical trial, the vaccine still requires regulatory approval before distribution.

Thanksgiving is likely to look different for nearly everybody this year. Even if your annual tradition simply includes watching a local parade, or partaking in a “Turkey trot,” the event will undoubtedly have coronavirus-related changes if it wasn’t outright canceled.

Following news of up to 90% coronavirus vaccine efficacy, AstraZeneca and Oxford University’s effort involves a more traditional method, as opposed to other vaccine candidate platforms.

A Texas family is using their personal experience to warn others against gathering for celebrations ahead of Thanksgiving after 12 of them allegedly contracted coronavirus at a birthday dinner held earlier this month, eventually spreading it to three others who didn’t go to the party.

Coronavirus vaccines are slated to be widely available by spring in Britain, an Oxford official said Monday. 

AstraZeneca and Oxford said Monday their vaccine was as much as 90% effective in preventing COVID-19, marking the latest candidate to inch closer toward approval.

In reporting that it's coronavirus vaccine reached up to 90% efficacy in clinical trials, AstraZeneca and Oxford University also noted that the jab was more effective when given in a half-dose regimen as opposed to a full. 

Oxford-AstraZeneca mark the third to prepare to file for emergency approval for a coronavirus vaccine candidate